The combination of resveratrol and conjugated linoleic acid attenuates the individual effects of these molecules on triacylglycerol metabolism in adipose tissue

European Journal of Nutrition

Volumn 53, Issue 2, 2014, Pages 575-582

  Arias, N ^a,b   Miranda, J ^a,b   Macarulla, M T ^a,b   Aguirre, L ^a,b   Fernandez Quintela A ^a,b   Andres Lacueva, C ^c,d   Urpi Sarda, M ^c,d   Portillo, M P ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Ministry of Science and Innovation   (Spain)

Author keywords

Adipose tissue; Combination; Conjugated linoleic acid; Lipases; Lipogenesis; Resveratrol

Indexed keywords

CALCIUM; CONJUGATED LINOLEIC ACID; FATTY ACID SYNTHASE; HEPARIN; LIPOPROTEIN LIPASE; RESVERATROL; SIRTUIN 1; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BODY FAT; CALCIUM CELL LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FOOD INTAKE; ISOMER; LIPID METABOLISM; MALE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; RICE STRIPE VIRUS;

ADIPOSE TISSUE; ANIMALS; CALCIUM; DRUG INTERACTIONS; FATTY ACID SYNTHASES; GENE EXPRESSION; LINOLEIC ACIDS, CONJUGATED; LIPASE; LIPOPROTEIN LIPASE; MALE; RATS; RATS, WISTAR; SIRTUIN 1; STILBENES; TRIGLYCERIDES;

EID: 84896722440     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0566-y     Document Type: Article

References (52)

1. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G (2006) Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 17:789-810
2. Wang YW, Jones PJ (2004) Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 28:941-955
3. Larsen TM, Toubro S, Astrup A (2003) Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 44:2234-2241
4. Navarro V, Miranda J, Churruca I, Fernández-Quintela A, Rodríguez V, Portillo M (2006) Effects of trans-10, cis-12 conjugated linoleic acid on body fat and serum lipids in young and adult hamsters. J Physiol Biochem 62:81-87
5. Salas-Salvado J, Marquez-Sandoval F, Bullo M (2006) Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr 46:479-488
6. Azain MJ, Hausman DB, Sisk MB, Flatt WP, Jewell DE (2000) Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number. J Nutr 130:1548-1554
7. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K et al (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49:1534-1542
8. Clement L, Poirier H, Niot I et al (2002) Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43:1400-1409
9. Faulconnier Y, Arnal MA, Patureau Mirand P, Chardigny JM, Chilliard Y (2004) Isomers of conjugated linoleic acid decrease plasma lipids and stimulate adipose tissue lipogenesis without changing adipose weight in post-prandial adult sedentary or trained Wistar rat. J Nutr Biochem 15:741-748
10. Kang K, Miyazaki M, Ntambi JM, Pariza MW (2004) Evidence that the anti-obesity effect of conjugated linoleic acid is independent of effects on stearoyl-CoA desaturase 1 expression and enzyme activity. Biochem Biophys Res Commun 315:532-537
11. Baur JA, Pearson KJ, Price NL et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342
12. Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122
13. Ahn J, Cho I, Kim S, Kwon D, Ha T (2008) Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepatol 49:1019-1028
14. Macarulla MT, Alberdi G, Gómez S et al (2009) Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet. J Physiol Biochem 65:369-376
15. Rivera L, Morón R, Zarzuelo A, Galisteo M (2009) Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77:1053-1063
16. Alberdi G, Rodríguez VM, Miranda J et al (2011) Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutr Metab (Lond) 8:29
17. Cho SJ, Jung UJ, Choi MS (2012) Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice. Br J Nutr 108:2166-2175
18. Timmers S, Konings E, Bilet L et al (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14:612-622
19. Picard F, Kurtev M, Chung N et al (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429:771-776
20. Rayalam S, Della-Fera MA, Yang JY, Park HJ, Ambati S, Baile CA (2007) Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J Nutr 137:2668-2673
21. Bai L, Pang WJ, Yang YJ, Yang GS (2008) Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem 307:129-140
22. Szkudelska K, Nogowski L, Szkudelski T (2009) Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J Steroid Biochem Mol Biol 113:17-24
23. Fischer-Posovszky P, Kukulus V, Tews D et al (2010) Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. Am J Clin Nutr 92:5-15
24. Chen S, Li Z, Li W, Shan Z, Zhu W (2011) Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK. Can J Physiol Pharmacol 89:793-799
25. Yang JY, Della-Fera MA, Rayalam S, Ambati S, Baile CA (2007) Enhanced pro-apoptotic and anti-adipogenic effects of genistein plus guggulsterone in 3T3-L1 adipocytes. BioFactors 30:159-169
26. Rayalam S, Della-Fera MA, Ambati S, Boyan B, Baile CA (2007) Enhanced effects of guggulsterone plus 1,25(OH)2D3 on 3T3-L1 adipocytes. Biochem Biophys Res Commun 364:450-456
27. Park HJ, Yang JY, Ambati S et al (2008) Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J Med Food 11:773-783
28. Rayalam S, Della-Fera MA, Ambati S, Yang JY, Park HJ, Baile CA (2008) Enhanced effects of 1,25 (OH)(2)D(3) plus genistein on adipogenesis and apoptosis in 3T3-L1 adipocytes. Obesity (Silver Spring) 16:539-546
29. Rayalam S, Yang JY, Della-Fera MA, Park HJ, Ambati S, Baile CA (2009) Anti-obesity effects of xanthohumol plus guggulsterone in 3T3-L1 adipocytes. J Med Food 12:846-853
30. Bruckbauer A, Zemel MB, Thorpe T et al (2012) Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond) 9:77
31. Brown J, McIntosh M (2003) Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity. J Nutr 133:3041-3046
32. Taylor CG, Zahradka P (2004) Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models. Am J Clin Nutr 79:1164S-1168S
33. Szkudelska K, Szkudelski T (2010) Resveratrol, obesity and diabetes. Eur J Pharmacol 635:1-8
34. Szkudelski T, Szkudelska K (2011) Anti-diabetic effects of resveratrol. Ann N Y Acad Sci 1215:34-39
35. Arias N, Macarulla MT, Aguirre L et al (2011) The combination of resveratrol and conjugated linoleic acid is not useful in preventing obesity. J Physiol Biochem 67:471-477
36. Navarro V, Zabala A, Macarulla MT et al (2003) Effects of conjugated linoleic acid on body fat accumulation and serum lipids in hamsters fed an atherogenic diet. J Physiol Biochem 59:193-199
37. Miranda J, Fernández-Quintela A, Macarulla MT et al (2009) A comparison between CLNA and CLA effects on body fat, serum parameters and liver composition. J Physiol Biochem 65:25-32
38. Del Prado M, Hernandez-Montes H, Villalpando S (1994) Characterization of a fluorometric method for lipoprotein lipase. Arch Med Res 25:331-335
39. Zabala A, Fernandez-Quintela A, Macarulla MT et al (2006) Effects of conjugated linoleic acid on skeletal muscle triacylglycerol metabolism in hamsters. Nutrition 22:528-533
40. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408
41. Andres-Lacueva C, Macarulla MT, Rotches-Ribalta M et al (2012) Distribution of resveratrol metabolites in liver, adipose tissue, and skeletal muscle in rats fed different doses of this polyphenol. J Agric Food Chem 60:4833-4840
42. Rotches-Ribalta M, Urpi-Sarda M, Llorach R et al (2012) Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method. J Chromatogr A 1265:105-113
43. Xu X, Storkson J, Kim S, Sugimoto K, Park Y, Pariza MW (2003) Short-term intake of conjugated linoleic acid inhibits lipoprotein lipase and glucose metabolism but does not enhance lipolysis in mouse adipose tissue. J Nutr 133:663-667
44. Kim MR, Park Y, Albright KJ, Pariza MW (2002) Differential responses of hamsters and rats fed high-fat or low-fat diets supplemented with conjugated linoleic acid. Nutrition research (New York, NY) 22: 715-722
45. Maier-Salamon A, Hagenauer B, Reznicek G, Szekeres T, Thalhammer T, Jäger W (2008) Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides. J Pharm Sci 97:1615-1628
46. Walle T (2011) Bioavailability of resveratrol. Ann N Y Acad Sci 1215:9-15
47. Kennedy A, Overman A, Lapoint K et al (2009) Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol. J Lipid Res 50:225-232
48. Kim JH, Mynatt RL, Moore JW, Woychik RP, Moustaid N, Zemel MB (1996) The effects of calcium channel blockade on agouti-induced obesity. FASEB J 10:1646-1652
49. Boon N, Hul GB, Stegen JH et al (2007) An intervention study of the effects of calcium intake on faecal fat excretion, energy metabolism and adipose tissue mRNA expression of lipid-metabolism related proteins. Int J Obes (Lond) 31:1704-1712
50. Zhang L, Lookene A, Wu G, Olivecrona G (2005) Calcium triggers folding of lipoprotein lipase into active dimers. J Biol Chem 280:42580-42591
51. Ponugoti B, Kim DH, Xiao Z et al (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 285:33959-33970
52. Howitz KT, Bitterman KJ, Cohen HY et al (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196